Clinical Trial Update: IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of pemvidutide in nonalcoholic steatohepatitis has completed, with results on its performance reported in the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Pemvidutide (Pemvidutide)

Snippet

Sponsor: Altimmune, Inc. | Conditions: Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | Status: COMPLETED